Affordable Access

deepdyve-link deepdyve-link
Publisher Website

A Phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignancies.

Authors
Type
Published Article
Journal
Investigational New Drugs
1573-0646
Publisher
Springer-Verlag
Publication Date
Volume
31
Issue
2
Pages
355–362
Identifiers
DOI: 10.1007/s10637-012-9821-y
PMID: 22615058
Source
Medline

Abstract

Statistics

Seen <100 times